Steatohepatitis due to FOLFIRINOX regimen in adjuvant pancreas cancer treatment mimicking liver metastasis.

Berna Bozkurt DumanTimuçin Çil

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2020)

FOLFIRINOX regimen is the most important combination in pancreas cancer adjuvant setting. This case shows us the different presentation of usual adverse event.

Keyphrases

locally advanced
early stage
papillary thyroid
squamous cell
rectal cancer
squamous cell carcinoma
radiation therapy
case report
emergency department
adverse drug
liver fibrosis